investments
Angelini Ventures leads Nuclidium’s €84 million funding round
The Swiss start-up is engaged in the development of copper-based radiopharmaceuticals for the treatment of cancer.
The Swiss start-up is engaged in the development of copper-based radiopharmaceuticals for the treatment of cancer.